You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A simple assay system for rapid detection of circulating tumor cells
SBC: TELOVISION, LLC Topic: NCIDESCRIPTION provided by applicant Metastasis or dissemination of primary tumor cells is the major cause of mortality in cancer patients Circulating tumor cells CTCs in the bloodstream are key players in the establishment of metastatic tumors Recent studies demonstrated that the number of CTCs present in patient blood directly correlate with cancer progression recurrence and survival rate ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Development of Peptide Antibiotic Nucleic Acids
SBC: NUBAD LLC Topic: NIAIDDESCRIPTION provided by applicant One of the challenges of research in infectious diseases is to find ways to use the increasing knowledge of the mechanisms underlying disease transformation and progression to develop novel therapeutic strategies for diseases such as increasing menace of bacterial infections Targeting specific RNA such as rRNA which are involved in proliferation and survival ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Corneal Endothelial Stem Cells for Treatment of Corneal Endothelial Dystrophies
SBC: RASHMIVU LLC Topic: NDESCRIPTION provided by applicant Corneal clouding caused by failure of the corneal endothelial deturgesence mechanism affects over million people in the US and well over million people worldwide It is the most common corneal disease and is historically a common cause of blindness Surgical treatment by corneal grafting has been successful when available but is limited by the availabili ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Silica Colloidal Crystals for High Resolution MALDI-MS of Glycoproteins
SBC: LI-COR, Inc. Topic: 100DESCRIPTION provided by applicant The product is a slide coated with silica colloidal crystals to combine protein electrophoresis with matrix assisted laser desorption ionization mass spectrometry MALDI MS detection giving superior performance in both The Phase II proposal will be to develop an instrument for facile application of the slide in proteomics of intat glycoproteins This propos ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Metal ion-functionalized soluble nanopolymers: A new analytical platform for plas
SBC: TYMORA ANALYTICAL OPERATIONS LLC Topic: 300DESCRIPTION provided by applicant Mass spectrometry based proteomics is an emerging technology that has seen possible applications everywhere The technique can potentially use one drop of our blood to reveal onset and progress of diseases Current Randamp D using plasma serum proteome sample sets however is severely limited by the high complexity and dynamic range of protein concentrations ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Universal amplifier system for high-fidelity multi-modal biosignal recordings
SBC: REFER2INPUT, LLC Topic: 213DESCRIPTION provided by applicant The measurement monitoring and use of bioelectric signals has evolved from the measurement of the electrical activity of the heart to encompass tissues ranging from cardiac skeletal and smooth muscles to brain and peripheral nerve tissues Together with this development has been the evolution of specialized equipment to capture and interpret these minute sig ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
A MapReduce-like Data-Intensive Processing Framework for Native Data Storage and Formats
SBC: RNET TECHNOLOGIES INC Topic: 01cMapReduce is a very popular data analytic framework that is widely used in both industry and scientific research. Despite the popularity of MapReduce, there are several obstacles to applying it for developing some commercial and scientific data analysis applications. The project will develop a Native data FOrmat MapREDuce-like framework, iNFORMER, based on OSUs SciMate architecture. The framework ...
STTR Phase I 2014 Department of Energy -
Durable High Temperature Coatings for Utility Scale Gas Turbine Hot Gas Path Components
SBC: UES INC Topic: 14cFor advanced gas turbines where turbine inlet temperature reaches 2650F and beyond, the current state-of-the-art thermal barrier coating (TBC) systems are not adequate to provide the needed protection for the metallic components of the turbine engine. Thus there is a need to develop new chemistries and architectures for TBC systems (both bond coats and top TBCs) with enhanced durability. For the ...
STTR Phase I 2014 Department of Energy -
Ground Penetrating Radar System and Algorithms for Fine Root Analysis
SBC: RNET TECHNOLOGIES INC Topic: 18bCurrent ground penetrating radar based root analysis techniques have been mainly targeted for coarse root analysis. In order to extend the GPR technology to fine root analysis, it is necessary to design an unconventional GPR system that provides root information in the entire area under observation with greater accuracy and penetration depth. Specialized signal/image processing algorithms applicab ...
STTR Phase I 2014 Department of Energy -
Combinatorial RXR-based therapeutics for Alzheimer's disease
SBC: REXCEPTOR, INC. Topic: NIADESCRIPTION (provided by applicant): The principle objective of this application is the development of safer and more effective combinatorial therapy for AD. ReXceptor, Inc. is developing new therapeutics for the treatment of AD based on stimulating the physiological clearance mechanisms of soluble forms of A from the brain. Bexarotene is an agonist of the ligand-activated transcription factor, r ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health